Edition:
United States

Dynavax Technologies Corp (DVAX.OQ)

DVAX.OQ on NASDAQ Stock Exchange Capital Market

5.70USD
26 May 2017
Change (% chg)

-- (--)
Prev Close
$5.70
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
173,138
52-wk High
$17.50
52-wk Low
$3.20

DVAX.OQ

Chart for DVAX.OQ

About

Dynavax Technologies Corporation is a clinical-stage immunotherapy company. The Company is focused on leveraging the body's innate and adaptive immune responses through toll-like receptor (TLR) stimulation. Its product candidates are being investigated for use in multiple cancer indications, as a vaccine for the prevention of... (more)

Overall

Beta: 1.60
Market Cap(Mil.): $278.12
Shares Outstanding(Mil.): 48.79
Dividend: --
Yield (%): --

Financials

  DVAX.OQ Industry Sector
P/E (TTM): -- 137.90 17.41
EPS (TTM): -2.82 -- --
ROI: -84.23 -8.48 -5.42
ROE: -84.57 -11.31 -4.68

BRIEF-Dynavax reports Q1 loss per share $0.60

* Q1 earnings per share view $-0.51 -- Thomson Reuters I/B/E/S

May 08 2017

BRIEF-Dynavax announces FDA acceptance

* Dynavax announces FDA acceptance for review of its complete response to November 2016 CRL and PDUFA action date for heplisav-b(tm)

Feb 28 2017

More From Around the Web

Earnings vs. Estimates